| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 19.64B | 20.68B | 19.30B | 18.49B | 17.02B | 17.22B |
| Gross Profit | 5.36B | 5.75B | 5.18B | 4.92B | 4.62B | 4.91B |
| EBITDA | 541.00M | 562.00M | 434.00M | 403.00M | 182.00M | 470.00M |
| Net Income | 241.00M | 244.00M | 81.00M | 284.00M | -326.00M | 198.00M |
Balance Sheet | ||||||
| Total Assets | 9.05B | 12.01B | 12.14B | 11.66B | 10.68B | 10.98B |
| Cash, Cash Equivalents and Short-Term Investments | 1.41B | 1.12B | 905.00M | 1.06B | 975.00M | 1.28B |
| Total Debt | 61.00M | 900.00M | 905.00M | 1.00B | 1.00B | 208.00M |
| Total Liabilities | 4.04B | 6.48B | 6.70B | 6.18B | 5.51B | 5.42B |
| Stockholders Equity | 5.00B | 5.53B | 5.43B | 5.48B | 5.16B | 5.56B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 454.00M | 140.00M | 107.00M | -917.00M | 930.00M |
| Operating Cash Flow | 0.00 | 624.00M | 241.00M | 130.00M | -805.00M | 1.04B |
| Investing Cash Flow | 0.00 | -150.00M | -153.00M | -43.00M | -205.00M | -168.00M |
| Financing Cash Flow | 0.00 | -259.00M | -241.00M | -2.00M | 707.00M | -520.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥16.75B | 13.03 | ― | 3.53% | 3.36% | -23.56% | |
68 Neutral | ¥14.28B | 9.66 | ― | 4.02% | 5.51% | -2.57% | |
66 Neutral | ¥3.07B | 10.86 | ― | 2.91% | 7.15% | 226.62% | |
65 Neutral | ¥9.22B | 9.64 | ― | 3.85% | -6.67% | 34.46% | |
63 Neutral | ¥20.02B | 27.91 | ― | ― | 25.92% | -10.55% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
59 Neutral | ¥15.71B | 23.80 | ― | 1.01% | 14.48% | -12.25% |